Functional Aspects:This antibody specifically recognizes Sialyl Lewisa containing glycolipids and does not cross-react with Lewisa, Lewisb or other structurally related molecules. The epitope Ca19-9 recognized by this antibody has been reported to be a useful marker of gastrointestinal and pancreatic cancers.